Department of Genetics, Reproduction and Fetal Medicine, Institute of Biomedicine of Seville (IBIS), University Hospital Virgen del Rocío/CSIC/University of Seville, Avenida Manuel Siurot, s/n, 41013 Seville, Spain.
Biomed Res Int. 2013;2013:585106. doi: 10.1155/2013/585106. Epub 2013 Apr 4.
Preimplantation genetic diagnosis (PGD) of single gene disorders, combined with HLA matching (PGD-HLA), has emerged as a tool for couples at risk of transmitting a genetic disease to select unaffected embryos of an HLA tissue type compatible with that of an existing affected child. Here, we present a novel one-step multiplex PCR to genotype a spectrum of STRs to simultaneously perform HLA typing and PGD for β-thalassemia. This method is being routinely used for PGD-HLA cycles in our department, with a genotyping success rate of 100%. As an example, we present the first successful PGD-HLA typing in Spain, which resulted in the birth of a boy and subsequent successful HSC transplantation to his affected brother, who is doing well 4 years following transplantation. The advantage of our method is that it involves only a round of single PCR for multiple markers amplification (up to 10 markers within the HLA and 6 markers at the β-globin loci). This strategy has allowed us to considerably reduce the optimization of the PCR method for each specific PGD-HLA family as well as the time to obtain molecular results in each cycle.
植入前遗传学诊断(PGD)单基因疾病,结合 HLA 配型(PGD-HLA),已成为一种工具,用于有遗传疾病风险的夫妇选择与现有患病孩子 HLA 组织类型相容的无疾病胚胎。在这里,我们提出了一种新的一步多重 PCR 方法,用于对一系列 STR 进行基因分型,以同时进行 HLA 分型和β-地中海贫血的 PGD。这种方法已在我们的科室中常规用于 PGD-HLA 周期,基因分型成功率为 100%。作为一个例子,我们展示了西班牙首例成功的 PGD-HLA 分型,随后成功地将造血干细胞移植到受影响的兄弟身上,移植后 4 年他的情况良好。我们的方法的优势在于,它只涉及一轮单 PCR 进行多个标记物的扩增(在 HLA 中最多可扩增 10 个标记物,在β-球蛋白基因座中最多可扩增 6 个标记物)。这种策略使我们能够大大减少每个特定 PGD-HLA 家族的 PCR 方法的优化,以及每个周期获得分子结果的时间。